安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMGN 安进

盘前交易 09-02 08:33:07 EDT

287.71

+2.10

+0.74%

盘前286.65

-1.06-0.37%

08:30 EDT

最高288.30	最低285.16	成交量130.28万
今开285.80	昨收285.61	日振幅1.10%
总市值1,549亿	流通市值1,545亿	总股本5.38亿
成交额3.74亿	换手率0.24%	流通股本5.37亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"安进","latestPrice":287.71,"timestamp":1756497600000,"preClose":285.61,"halted":0,"volume":1302804,"hourTrading":{"tag":"盘前","latestPrice":286.65,"preClose":287.71,"latestTime":"08:30 EDT","volume":1283,"amount":368239.94991,"timestamp":1756816213922},"delay":0,"floatShares":536994627,"shares":538361851,"eps":12.23,"marketStatus":"盘前交易","change":2.1,"latestTime":"09-02 08:33:07 EDT","open":285.8,"high":288.2999,"low":285.16,"amount":374366500.82171994,"amplitude":0.010994,"askPrice":286.77,"askSize":11,"bidPrice":285,"bidSize":4,"shortable":3,"etf":0,"ttmEps":12.23,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756819800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":287.71,"dividendRate":0.032185,"preHourTrading":{"tag":"盘前","latestPrice":286.65,"preClose":287.71,"latestTime":"08:30 EDT","volume":1283,"amount":368239.94991,"timestamp":1756816213922},"postHourTrading":{"tag":"盘后","latestPrice":288,"preClose":287.71,"latestTime":"19:35 EDT","volume":135067,"amount":38861292.10398,"timestamp":1756510501956},"volumeRatio":0.773915807026303,"impliedVol":0.2262,"impliedVolPercentile":0.0602},"requestUrl":"/m/hq/s/AMGN/tweets","defaultTab":"tweets","newsList":[{"id":"2562781487","title":"Piper Sandler上调安进目标价至342美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562781487","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562781487?lang=zh_cn&edition=full","pubTime":"2025-08-26 17:29","pubTimestamp":1756200574,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0058720904.USD","BK4581","LU1061106388.HKD","LU2242652126.USD","LU2468319806.SGD","BK4588","BK4599","LU0868494617.USD","BK4139","LU0289739699.SGD","LU1057294990.SGD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4533","LU0122379950.USD","AMGN","IE00BFTCPJ56.SGD","BK4566","IE0002141913.USD","LU2242646821.SGD","LU0109394709.USD","BK4585","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU1571399168.USD","BK4534","IE0009355771.USD","LU2089984988.USD","SG9999001440.SGD","LU2112291526.USD"],"gpt_icon":0},{"id":"2562247520","title":"Amgen Says US FDA Broadens Approved Use of Repatha","url":"https://stock-news.laohu8.com/highlight/detail?id=2562247520","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562247520?lang=zh_cn&edition=full","pubTime":"2025-08-25 21:40","pubTimestamp":1756129209,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) said Monday that the US Food and Drug Administration has broadened the approved use of Repatha to include adults at increased risk for major adverse cardiovascular events due to uncontrol","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"安进表示美国FDA扩大了Repatha的批准用途","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0868494617.USD","LU1983299246.USD","BK4566","LU0289739699.SGD","LU2242652126.USD","BK4588","BK4534","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4585","LU1023059063.AUD","IE00BJT1NW94.SGD","LU0109394709.USD","AMGN","BK4581","LU0889565916.HKD","LU2112291526.USD","BK4533","IE00BJJMRZ35.SGD","LU2089984988.USD","SG9999001440.SGD","LU0058720904.USD","IE0002141913.USD","LU1057294990.SGD","LU1061106388.HKD","BK4599","LU0122379950.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU1571399168.USD","BK4139","IE00B2B36J28.USD","LU2242646821.SGD"],"gpt_icon":0},{"id":"2562324229","title":"Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2562324229","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562324229?lang=zh_cn&edition=full","pubTime":"2025-08-25 21:22","pubTimestamp":1756128164,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to lower pre-bell Monday, with the Health Care Select Sector SPDR Fund  inactive and the iShares Biotechnology ETF  down 0.2%.Argenx  stock was nearly 4% higher after the company said a phase 3 study of its drug Vyvgart met its primary endpoint in treating patients with AChR-Ab seronegative generalized myasthenia gravis, an autoimmune disease.Axogen  shares were down more than 10% after the company said the US Food and Drug Administration has extended the review deadline for its marketing application for the Avance Nerve Graft by three months.BeOne Medicines  shares were up more than 2% after the company said it has agreed to sell its royalty rights, excluding China, on Amgen's  lung cancer drug, Imdelltra, to Royalty Pharma  for up to $950 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"行业更新：医疗保健股周一盘前持平至走低","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","LU2242646821.SGD","BK4585","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4526","IE0009355771.USD","LU0289739699.SGD","LU1571399168.USD","LU2242652126.USD","XLV","LU0058720904.USD","SG9999001440.SGD","LU1983299246.USD","LU0320765992.SGD","LU1057294990.SGD","LU0868494617.USD","ARGX","ONC","LU1061106388.HKD","RPRX","BK4581","IE00B4R5TH58.HKD","AMGN","LU2112291526.USD","LU2089984988.USD","BK4007","BK4534","IBB","LU1023059063.AUD","IE00B2B36J28.USD","LU0109394709.USD","BK4505","IE0002141913.USD","LU2468319806.SGD","BK4599","BK4082","LU0122379950.USD","LU0889565916.HKD","BK4533","BK4566","AXGN","BK4139","BK4588"],"gpt_icon":0},{"id":"2562421744","title":"Piper Sandler Adjusts Price Target on Amgen to $342 From $328, Maintains Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2562421744","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562421744?lang=zh_cn&edition=full","pubTime":"2025-08-25 17:39","pubTimestamp":1756114792,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) has an average rating of overweight and mean price target of $310.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"Piper Sandler将安进目标价从328美元调整至342美元，维持跑赢大盘评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMGN"],"gpt_icon":0},{"id":"2560174127","title":"Rothschild & Co Redburn Adjusts Price Target on Amgen to $180 From $185, Maintains Sell Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2560174127","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560174127?lang=zh_cn&edition=full","pubTime":"2025-08-20 18:20","pubTimestamp":1755685221,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) has an average rating of overweight and mean price target of $316, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"Rothschild&Co Redburn将安进目标价从185美元调整至180美元，维持卖出评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMGN"],"gpt_icon":0},{"id":"2559916918","title":"Daiwa Securities Adjusts Price Target on Amgen to $310 From $350, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2559916918","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559916918?lang=zh_cn&edition=full","pubTime":"2025-08-15 18:44","pubTimestamp":1755254663,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) has an average rating of overweight and mean price target of $317.42, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"大和证券将安进目标价从350美元调整至310美元，维持跑赢大盘评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMGN"],"gpt_icon":0},{"id":"2559398827","title":"伯恩斯坦下调安进目标价至335美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559398827","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559398827?lang=zh_cn&edition=full","pubTime":"2025-08-13 23:25","pubTimestamp":1755098750,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0009355771.USD","LU0868494617.USD","LU2242646821.SGD","BK4581","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1983299246.USD","LU0109394709.USD","IE00B2B36J28.USD","SG9999001440.SGD","LU0889565916.HKD","IE0002141913.USD","LU0320765992.SGD","BK4566","LU0289739699.SGD","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","LU0058720904.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU2468319806.SGD","LU0122379950.USD","BK4599","BK4585","BK4139","LU2089984988.USD","AMGN","BK4533","LU2242652126.USD","BK4588","IE00BFTCPJ56.SGD","BK4534"],"gpt_icon":0},{"id":"2559988530","title":"Bernstein Adjusts Price Target on Amgen to $335 From $350","url":"https://stock-news.laohu8.com/highlight/detail?id=2559988530","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559988530?lang=zh_cn&edition=full","pubTime":"2025-08-13 22:46","pubTimestamp":1755096386,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) has an average rating of overweight and mean price target of $317.74, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"伯恩斯坦将安进目标价从350美元调整至335美元","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMGN"],"gpt_icon":0},{"id":"2559700622","title":"13F报告显示德意志银行二季度建仓做多iShares标普小盘股600成长ETF等。增持英伟达、Meta Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2559700622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559700622?lang=zh_cn&edition=full","pubTime":"2025-08-13 06:15","pubTimestamp":1755036935,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0210533765.USD","3NVD.UK","TSLL","LU0265550946.USD","META","MSFT","TSYW.SI","NVDL","LU1670711040.USD","BK4503","NVD3.UK","BRK.A","LU0444971666.USD","NVDX","USJW.SI","FB","NVIW.SI","NVDS","510280","NVDY","EEMA","LU0130102774.USD","NVDS.UK","GOOGL","UNH","AMGN","FDN","IE00B4R5TH58.HKD","MACW.SI","TSLA","NVD2.UK","GOOG","0H7D.UK","BK4551","MRK","LU0347712357.USD","NVDA","LU2506952097.USD","NVDD","DB","AMZN","NVD","ESmain","NVDU","LU0080751232.USD","SNVD.UK","LU2764263039.SGD","USAW.SI","2NVD.UK","AAPL"],"gpt_icon":0},{"id":"2558681260","title":"安进2025财年第二财季实现净利润14.32亿美元，同比增加91.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558681260","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558681260?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841695,"startTime":"0","endTime":"0","summary":"8月11日，安进公布财报，公告显示公司2025财年第二财季净利润为14.32亿美元，同比增加91.96%；其中营业收入为91.67亿美元，同比增加10.01%，每股基本收益为2.66美元。从资产负债表来看，安进总负债804.69亿美元，其中短期债务24.44亿美元，资产负债比为1.10，流动比率为1.31。机构评级：截至2025年8月11日，当前有23家机构对安进目标价做出预测，其中目标均价为317.96美元，其中最低目标价为215.00美元，最高目标价为405.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000346a480578d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMGN"],"gpt_icon":0},{"id":"2558508085","title":"安进8月8日成交额为5.19亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558508085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558508085?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:16","pubTimestamp":1754702206,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，安进成交额为5.19亿美元，成交额较昨日减少29.72%，当日成交量为180.34万股。安进于2025年8月8日涨1.24%，报288.23美元，该股过去5个交易日跌2.91%，年初至今涨12.47%，过去60日涨7.52%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809091656a6dbdd09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","BK4585","LU0109394709.USD","LU0320765992.SGD","LU2242652126.USD","BK4139","SG9999001440.SGD","IE0009355771.USD","LU2242646821.SGD","AMGN","LU1061106388.HKD","LU0058720904.USD","IE00B2B36J28.USD","BK4581","BK4566","LU0289739699.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU2112291526.USD","LU2089984988.USD","LU1057294990.SGD","LU1571399168.USD","LU0122379950.USD","LU1983299246.USD","BK4588","BK4599","IE00BFTCPJ56.SGD","BK4533","LU1023059063.AUD","LU2468319806.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","BK4534"],"gpt_icon":0},{"id":"2557111561","title":"HSBC Adjusts Amgen Price Target to $343 From $337, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2557111561","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557111561?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:38","pubTimestamp":1754573882,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) has an average rating of overweight and mean price target of $317.96, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"汇丰将安进目标价从337美元调整至343美元，维持买入评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HSBC","AMGN","00005"],"gpt_icon":0},{"id":"2557584949","title":"安进8月6日成交额为13.06亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557584949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557584949?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:16","pubTimestamp":1754529414,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，安进成交额为13.06亿美元，成交额较昨日增加63.52%，当日成交量为457.62万股。安进于2025年8月6日跌5.14%，报284.67美元，该股过去5个交易日跌5.54%，年初至今涨11.08%，过去60日涨8.03%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807091658a479b309&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU0889565916.HKD","LU1983299246.USD","LU0289739699.SGD","BK4581","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4534","IE0002141913.USD","LU2468319806.SGD","BK4585","LU0868494617.USD","IE00B2B36J28.USD","LU2112291526.USD","BK4566","LU1023059063.AUD","SG9999001440.SGD","LU2089984988.USD","LU0320765992.SGD","IE0009355771.USD","BK4139","LU2242652126.USD","LU1061106388.HKD","LU1571399168.USD","LU0122379950.USD","LU0058720904.USD","IE00BJT1NW94.SGD","BK4588","IE00BJJMRZ35.SGD","AMGN","BK4599","IE00B4R5TH58.HKD","LU2242646821.SGD"],"gpt_icon":0},{"id":"1155375252","title":"异动解读 | 安进盘中大跌5.98%，Q2业绩超预期未能提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1155375252","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155375252?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:46","pubTimestamp":1754506006,"startTime":"0","endTime":"0","summary":"周三盘中，生物科技巨头安进股价大幅下跌5.98%，截至发稿时报292.60美元。这一跌幅引起了市场的广泛关注，尤其是在公司刚刚公布了超预期的第二季度业绩之后。根据安进最新发布的财报，公司2025年第二季度调整后每股收益达到6.02美元，显著高于分析师预期的5.26美元。分析人士指出，安进股价的下跌可能反映了投资者对公司未来增长前景的担忧。尽管本季度业绩亮眼，但市场可能担心这种强劲表现是否可持续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMGN"],"gpt_icon":0},{"id":"2557430181","title":"Amgen Stock Sinks As Market Eyes MariTide's Next Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2557430181","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557430181?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:19","pubTimestamp":1754504341,"startTime":"0","endTime":"0","summary":"Amgen beat Q2 earnings and revenue expectations, raised 2025 guidance, and reported strong product sales growth across key therapies.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"市场关注MariTide的下一步行动，安进股价下跌","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/08/46917706/amgen-stock-sinks-as-market-eyes-maritides-next-move","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4585","LU2112291526.USD","IE0002141913.USD","AMGN","BK4599","LU0889565916.HKD","SG9999001440.SGD","BK4588","BK4581","BK4139","LU0320765992.SGD","BK4533","BK4566","LU2089984988.USD","LU0289739699.SGD","LU1061106388.HKD","IE0009355771.USD","BK4534","LU0122379950.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU1571399168.USD","LU2242646821.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1057294990.SGD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU1983299246.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2557308381","title":"安进跌2.49% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2557308381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557308381?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:31","pubTimestamp":1754487111,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时31分，安进股票出现波动，股价大幅跳水2.49%。截至发稿，该股报292.60美元/股，成交量11.4978万股，换手率0.02%，振幅2.42%。安进股票所在的制药行业中，整体跌幅为1.01%。消息层面，截至21时31分，《安进Q2调整后EPS达6.02美元，超预期》资讯为影响安进的重要信息。该信息摘要如下：2025年8月6日，安进发布2025年第二季度财报，调整后每股收益为6.02美元，高于分析师预期的5.26美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213152a478d823&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1057294990.SGD","SG9999001440.SGD","BK4534","BK4585","IE00BJT1NW94.SGD","BK4139","IE0009355771.USD","LU1983299246.USD","BK4566","LU0868494617.USD","LU1023059063.AUD","LU1061106388.HKD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","LU0109394709.USD","BK4588","BK4581","AMGN","LU2468319806.SGD","BK4599","LU0289739699.SGD","LU0122379950.USD","LU2242652126.USD","LU0058720904.USD","LU2112291526.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2089984988.USD","BK4533"],"gpt_icon":0},{"id":"2557375195","title":"RBC Lifts Price Target on Amgen to $330 From $320, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2557375195","media":"MT Newswires Live","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557375195?lang=zh_cn&edition=full","pubTime":"2025-08-06 19:01","pubTimestamp":1754478075,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) has an average rating of overweight and mean price target of $317.61, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"加拿大皇家银行将安进目标价从320美元上调至330美元，维持跑赢大盘评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMGN"],"gpt_icon":0},{"id":"2557509340","title":"安进Q2净利润同比大增92% 上调全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2557509340","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557509340?lang=zh_cn&edition=full","pubTime":"2025-08-06 13:43","pubTimestamp":1754459035,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2112291526.USD","BK4139","IE0009355771.USD","BK4588","IE00BJJMRZ35.SGD","LU0889565916.HKD","AMGN","BK4599","LU0320765992.SGD","LU0868494617.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1023059063.AUD","LU2242646821.SGD","LU2089984988.USD","BK4581","LU1057294990.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4566","IE0002141913.USD","BK4585","BK4533","LU1061106388.HKD","LU0058720904.USD","LU0109394709.USD","LU2242652126.USD","LU2468319806.SGD","LU0122379950.USD","LU0289739699.SGD","SG9999001440.SGD","BK4534","LU1983299246.USD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2557346172","title":"安进8月5日成交额为7.99亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557346172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557346172?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:16","pubTimestamp":1754443006,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，安进成交额为7.99亿美元，成交额较昨日增加14.65%，当日成交量为266.41万股。安进于2025年8月5日跌0.62%，报300.08美元，该股过去5个交易日跌1.15%，年初至今涨17.09%，过去60日涨11.28%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806091653a6d56add&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0868494617.USD","LU0058720904.USD","BK4566","LU1571399168.USD","LU1057294990.SGD","LU2112291526.USD","LU1061106388.HKD","LU2242652126.USD","BK4599","LU0320765992.SGD","LU1023059063.AUD","BK4533","AMGN","BK4585","LU0289739699.SGD","LU0889565916.HKD","SG9999001440.SGD","IE0002141913.USD","BK4534","LU2468319806.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2242646821.SGD","LU2089984988.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","BK4588","LU0122379950.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4139","BK4581","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2557129603","title":"安进Q2调整后EPS达6.02美元，超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2557129603","media":"DoNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557129603?lang=zh_cn&edition=full","pubTime":"2025-08-06 05:08","pubTimestamp":1754428082,"startTime":"0","endTime":"0","summary":"2025年8月6日，安进发布2025年第二季度财报，调整后每股收益（EPS）为6.02美元，高于分析师预期的5.26美元。公司营收和利润均实现增长，主要得益于核心产品销售表现强劲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080605091794d1fd8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMGN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":-0.0205},{"period":"1month","weight":-0.0453},{"period":"3month","weight":-0.0016},{"period":"6month","weight":-0.0661},{"period":"1year","weight":-0.1308},{"period":"ytd","weight":0.1039}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.0944},{"period":"6month","weight":0.0856},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"安进公司于1980年在加利福尼亚成立，并于1987年成为特拉华州的一家公司。该公司发现、开发、制造和交付创新药物，以对抗世界上一些最棘手的疾病。该公司专注于高度未满足的医疗需求领域，并利用其专业知识努力寻求能够显著改善人们生活的解决方案，同时还能减轻疾病带来的社会和经济负担。该公司在40多年前帮助启动了生物技术产业，并已成长为世界领先的独立生物技术公司之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.034093},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.001155},{"month":3,"riseRate":0.52381,"avgChangeRate":0.019224},{"month":4,"riseRate":0.452381,"avgChangeRate":-0.002852},{"month":5,"riseRate":0.52381,"avgChangeRate":0.024179},{"month":6,"riseRate":0.5,"avgChangeRate":0.003875},{"month":7,"riseRate":0.767442,"avgChangeRate":0.052562},{"month":8,"riseRate":0.604651,"avgChangeRate":0.004451},{"month":9,"riseRate":0.52381,"avgChangeRate":0.002807},{"month":10,"riseRate":0.52381,"avgChangeRate":0.020682},{"month":11,"riseRate":0.619048,"avgChangeRate":0.019128},{"month":12,"riseRate":0.642857,"avgChangeRate":0.047779}],"exchange":"NASDAQ","name":"安进","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安进,AMGN,安进股票,安进股票老虎,安进股票老虎国际,安进行情,安进股票行情,安进股价,安进股市,安进股票价格,安进股票交易,安进股票购买,安进股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}